{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T04:20:23Z","timestamp":1783225223442,"version":"3.54.6"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.bbr.2012.01.016","type":"journal-article","created":{"date-parts":[[2012,1,17]],"date-time":"2012-01-17T02:37:03Z","timestamp":1326767823000},"page":"208-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease"],"prefix":"10.1016","volume":"229","author":[{"given":"Adalberto A.","family":"Castro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karina","family":"Ghisoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Latini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo\u00e3o","family":"Quevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla I.","family":"Tasca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui D.S.","family":"Prediger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2012.01.016_bib0005","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pneurobio.2007.10.003","article-title":"Disease-modifying drugs and Parkinson's disease","volume":"84","author":"Allain","year":"2008","journal-title":"Prog Neurobiol"},{"key":"10.1016\/j.bbr.2012.01.016_bib0010","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00702-004-0168-1","article-title":"Cognitive dysfunction and dementia in Parkinson's disease","volume":"111","author":"Bosboom","year":"2004","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2012.01.016_bib0015","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00441-004-0956-9","article-title":"Stages in the development of Parkinson's disease-related pathology","volume":"318","author":"Braak","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.bbr.2012.01.016_bib0020","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1037\/h0077266","article-title":"Olfactory recognition of conspecifics by domestic Norway rats","volume":"90","author":"Carr","year":"1976","journal-title":"J Comp Physiol Psychol"},{"key":"10.1016\/j.bbr.2012.01.016_bib0025","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1474-4422(06)70373-8","article-title":"Non-motor symptoms of Parkinson's disease: diagnosis and management","volume":"5","author":"Chaudhuri","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bbr.2012.01.016_bib0030","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/sj.mp.4001893","article-title":"Valproate protects dopaminergic neurons in midbrain neuron\/glia cultures by stimulating the release of neurotrophic factors from astrocytes","volume":"11","author":"Chen","year":"2006","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbr.2012.01.016_bib0035","doi-asserted-by":"crossref","first-page":"6039","DOI":"10.1074\/jbc.274.10.6039","article-title":"Long term lithium treatment suppresses p53 and Bax expression but increases Bcl-2 expression. A prominent role in neuroprotection against excitotoxicity","volume":"274","author":"Chen","year":"1999","journal-title":"J Biol Chem"},{"key":"10.1016\/j.bbr.2012.01.016_bib0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0014-2999(84)90221-8","article-title":"Neurochemical and behavioral effects of systemic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat","volume":"100","author":"Chiueh","year":"1984","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2012.01.016_bib0045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1034\/j.1399-5618.2002.01179.x","article-title":"Neuroprotective effects of lithium in cultured cells and animal models of diseases","volume":"4","author":"Chuang","year":"2002","journal-title":"Bipolar Disord"},{"key":"10.1016\/j.bbr.2012.01.016_bib0050","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1615\/CritRevNeurobiol.v16.i12.90","article-title":"Neuroprotective and neurotrophic actions of the mood stabilizer lithium: can it be used to treat neurodegenerative diseases?","volume":"16","author":"Chuang","year":"2004","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.bbr.2012.01.016_bib0055","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0006-8993(91)91365-8","article-title":"Extracellular dopamine increase in neonatal olfactory bulb during odor preference training","volume":"564","author":"Coopersmith","year":"1991","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2012.01.016_bib0060","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/BF00518192","article-title":"Modulation of social memory in male rats by neurohypophyseal peptides","volume":"91","author":"Dantzer","year":"1987","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2012.01.016_bib0065","doi-asserted-by":"crossref","first-page":"e11383","DOI":"10.1371\/journal.pone.0011383","article-title":"Valproate administered after traumatic brain injury provides neuroprotection and improves cognitive function in rats","volume":"5","author":"Dash","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbr.2012.01.016_bib0070","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1126\/science.1087753","article-title":"Molecular pathways of neurodegeneration in Parkinson's disease","volume":"302","author":"Dawson","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.bbr.2012.01.016_bib0075","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/nn941","article-title":"Neuroprotective and neurorestorative strategies for Parkinson's disease","volume":"5","author":"Dawson","year":"2002","journal-title":"Nat Neurosci"},{"key":"10.1016\/j.bbr.2012.01.016_bib0080","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0006-8993(96)00934-1","article-title":"The effects of intranasal infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) upon catecholamine concentrations within olfactory bulbs and corpus striatum of male mice","volume":"741","author":"Dluzen","year":"1996","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2012.01.016_bib0085","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/0006-8993(93)90860-P","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) disrupts social memory\/recognition processes in the male mouse","volume":"609","author":"Dluzen","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2012.01.016_bib0090","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S0304-3940(98)00691-0","article-title":"Olfactory bulb norepinephrine depletion abolishes vasopressin and oxytocin preservation of social recognition responses in rats","volume":"254","author":"Dluzen","year":"1998","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2012.01.016_bib0095","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1212\/WNL.38.8.1237","article-title":"Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration","volume":"38","author":"Doty","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.bbr.2012.01.016_bib0100","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0006-8993(88)90917-1","article-title":"Effects of intrabulbar injections of 6-hydroxydopamine on ethyl acetate odor detection in castrate and non-castrate male rats","volume":"444","author":"Doty","year":"1988","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2012.01.016_bib0105","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/BF00451680","article-title":"Influence of the D2 dopamine receptor agonist quinpirole on the odor detection performance of rat before and after spiperone administration","volume":"98","author":"Doty","year":"1989","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2012.01.016_bib0110","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/PL00007725","article-title":"Cognitive deficits in Parkinson's disease","volume":"244","author":"Dubois","year":"1997","journal-title":"J Neurol"},{"key":"10.1016\/j.bbr.2012.01.016_bib0115","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1124\/mol.106.027912","article-title":"Pharmacological inhibition of histone deacetylases by suberoylanilide hydroxamic acid specifically alters gene expression and reduces ischemic injury in the mouse brain","volume":"70","author":"Faraco","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bbr.2012.01.016_bib0120","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1139\/jpn.0637","article-title":"Effects of lithium and valproate on amphetamine-induced oxidative stress generation in an animal model of mania","volume":"31","author":"Frey","year":"2006","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.bbr.2012.01.016_bib0125","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/cne.902660302","article-title":"Evidence of coexistence of GABA and dopamine in neurons of the rat olfactory bulb","volume":"266","author":"Gall","year":"1987","journal-title":"J Comp Neurol"},{"issue":"Suppl. 1","key":"10.1016\/j.bbr.2012.01.016_bib0130","doi-asserted-by":"crossref","first-page":"I31","DOI":"10.1007\/s00415-003-1106-y","article-title":"The relevance of preclinical studies for the treatment of Parkinson's disease","volume":"250","author":"Gerlach","year":"2003","journal-title":"J Neurol"},{"key":"10.1016\/j.bbr.2012.01.016_bib0135","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbr.2008.12.032","article-title":"A role for nitrergic system in the antidepressant-like effects of chronic lithium treatment in the mouse forced swimming test","volume":"200","author":"Ghasemi","year":"2009","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2012.01.016_bib0140","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/0306-4522(83)90206-3","article-title":"Neurochemistry of the vertebrate olfactory bulb","volume":"10","author":"Halasz","year":"1983","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2012.01.016_bib0145","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.0022-3042.2001.00728.x","article-title":"Lithium protection against glutamate excitotoxicity in rat cerebral cortical neurons: involvement of NMDA receptor inhibition possibly by decreasing NR2B tyrosine phosphorylation","volume":"80","author":"Hashimoto","year":"2002","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2012.01.016_bib0150","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.parkreldis.2011.03.003","article-title":"Valproate for the treatment of medication-induced impulse-control disorders in three patients with Parkinson's disease","volume":"17","author":"Hicks","year":"2011","journal-title":"Parkinsonism Relat Disord"},{"key":"10.1016\/j.bbr.2012.01.016_bib0155","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1097\/FBP.0b013e3283323c75","article-title":"Intradorsal hippocampal microinjection of lithium reverses morphine-induced impairment of memory in mice: interactions with dopamine receptor mechanism(s)","volume":"20","author":"Houghoghi","year":"2009","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bbr.2012.01.016_bib0160","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.jpsychires.2010.05.011","article-title":"Lithium and valproate modulate antioxidant enzymes and prevent ouabain-induced oxidative damage in an animal model of mania","volume":"45","author":"Jornada","year":"2011","journal-title":"J Psychiatr Res"},{"key":"10.1016\/j.bbr.2012.01.016_bib0165","doi-asserted-by":"crossref","first-page":"3521","DOI":"10.1073\/pnas.84.10.3521","article-title":"Correlation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity with blood\u2013brain barrier monoamine oxidase activity","volume":"84","author":"Kalaria","year":"1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2012.01.016_bib0170","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.neuroscience.2011.08.010","article-title":"Protective effects of valproic acid on the nigrostriatal dopamine system in a 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"194","author":"Kidd","year":"2011","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2012.01.016_bib0175","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1523\/JNEUROSCI.0096-06.2006","article-title":"Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity","volume":"26","author":"Leng","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2012.01.016_bib0180","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1523\/JNEUROSCI.5467-07.2008","article-title":"Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition","volume":"28","author":"Leng","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2012.01.016_bib0185","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1146\/annurev.neuro.26.043002.094919","article-title":"Epidemiology of neurodegeneration","volume":"26","author":"Mayeux","year":"2003","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.bbr.2012.01.016_bib0190","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1007\/s12640-009-9090-5","article-title":"Valproic acid is neuroprotective in the rotenone rat model of Parkinson's disease: involvement of alpha-synuclein","volume":"17","author":"Monti","year":"2010","journal-title":"Neurotox Res"},{"key":"10.1016\/j.bbr.2012.01.016_bib0195","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1471-4159.2007.04778.x","article-title":"Alpha-synuclein protects cerebellar granule neurons against 6-hydroxydopamine-induced death","volume":"103","author":"Monti","year":"2007","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2012.01.016_bib0200","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1007\/s00702-010-0464-x","article-title":"Proanthocyanidin-rich fraction from Croton celtidifolius Baill confers neuroprotection in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine rat model of Parkinson's disease","volume":"117","author":"Moreira","year":"2010","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2012.01.016_bib0205","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.neuroscience.2007.09.063","article-title":"Chronic lithium treatment magnifies learning in rats","volume":"150","author":"Nocjar","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2012.01.016_bib0210","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1097\/00001756-199806220-00031","article-title":"Neuroprotective effects of chronic lithium on focal cerebral ischemia in rats","volume":"9","author":"Nonaka","year":"1998","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2012.01.016_bib0215","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1017\/S0317167100023970","article-title":"Treatment of Parkinson's disease with sodium valproate: clinical, pharmacological, and biochemical observations","volume":"6","author":"Nutt","year":"1979","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.bbr.2012.01.016_bib0220","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1073\/pnas.95.10.5789","article-title":"Transgenic mice expressing human Bcl-2 in their neurons are resistant to 6-hydroxydopamine and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity","volume":"95","author":"Offen","year":"1998","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2012.01.016_bib0225","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/1073858404266776","article-title":"Cognitive dysfunction in Parkinson's disease: the role of frontostriatal circuitry","volume":"10","author":"Owen","year":"2004","journal-title":"Neuroscientist"},{"key":"10.1016\/j.bbr.2012.01.016_bib0230","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/0006-8993(95)00934-G","article-title":"A protective effect of lithium on rat behaviour altered by ibotenic acid lesions of the basal forebrain cholinergic system","volume":"695","author":"Pascual","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2012.01.016_bib0235","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2012.01.016_bib0240","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s12640-011-9281-8","article-title":"Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease","volume":"21","author":"Prediger","year":"2012","journal-title":"Neurotox Res"},{"key":"10.1016\/j.bbr.2012.01.016_bib0245","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2174\/138161211795164095","article-title":"The intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): a new rodent model to test palliative and neuroprotective agents for Parkinson's disease","volume":"17","author":"Prediger","year":"2011","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.bbr.2012.01.016_bib0250","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s12640-009-9087-0","article-title":"Single intranasal administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in C57BL\/6 mice models early preclinical phase of Parkinson's disease","volume":"17","author":"Prediger","year":"2010","journal-title":"Neurotox Res"},{"key":"10.1016\/j.bbr.2012.01.016_bib0255","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.expneurol.2006.07.001","article-title":"The risk is in the air: intranasal administration of MPTP to rats reproducing clinical features of Parkinson's disease","volume":"202","author":"Prediger","year":"2006","journal-title":"Exp Neurol"},{"key":"10.1016\/j.bbr.2012.01.016_bib0260","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbr.2003.11.009","article-title":"Facilitation of short-term social memory by ethanol in rats is mediated by dopaminergic receptors","volume":"153","author":"Prediger","year":"2004","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2012.01.016_bib0265","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.neurobiolaging.2004.08.012","article-title":"Caffeine reverses age-related deficits in olfactory discrimination and social recognition memory in rats. Involvement of adenosine A1 and A2A receptors","volume":"26","author":"Prediger","year":"2005","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.bbr.2012.01.016_bib0270","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1097\/01.fbp.0000166825.62130.9a","article-title":"Antagonistic interaction between adenosine A2A and dopamine D2 receptors modulates the social recognition memory in reserpine-treated rats","volume":"16","author":"Prediger","year":"2005","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bbr.2012.01.016_bib0275","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/j.1749-6632.2009.03885.x","article-title":"Risk is in the air: an intranasal MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) rat model of Parkinson's disease","volume":"1170","author":"Prediger","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.bbr.2012.01.016_bib0280","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1136\/jnnp.41.8.702","article-title":"Sodium valproate in the treatment of levodopa-induced dyskinesia","volume":"41","author":"Price","year":"1978","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.bbr.2012.01.016_bib0285","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1084\/jem.20081588","article-title":"Valproic acid inhibits Abeta production, neuritic plaque formation, and behavioral deficits in Alzheimer's disease mouse models","volume":"205","author":"Qing","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/j.bbr.2012.01.016_bib0290","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1472-8206.1999.tb00348.x","article-title":"The effect of lithium administration in animal models of depression: a short review","volume":"13","author":"Redrobe","year":"1999","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1016\/j.bbr.2012.01.016_bib0295","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/BF01249445","article-title":"Time course of nigrostriatal degeneration in Parkinson's disease. A detailed study of influential factors in human brain amine analysis","volume":"38","author":"Riederer","year":"1976","journal-title":"J Neural Transm"},{"key":"10.1016\/j.bbr.2012.01.016_bib0300","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1097\/00001756-199210000-00003","article-title":"Apomorphine disrupts odour-induced patterns of glomerular activation in the olfactory bulb","volume":"3","author":"Sallaz","year":"1992","journal-title":"Neuroreport"},{"key":"10.1016\/j.bbr.2012.01.016_bib0305","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2012.01.016_bib0310","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1037\/0735-7044.98.5.908","article-title":"Chemosensory and hormonal mediation of social memory in male rats","volume":"98","author":"Sawyer","year":"1984","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.bbr.2012.01.016_bib0315","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s12640-009-9061-x","article-title":"Progressive dopaminergic degeneration in the chronic MPTPp mouse model of Parkinson's disease","volume":"16","author":"Schintu","year":"2009","journal-title":"Neurotox Res"},{"key":"10.1016\/j.bbr.2012.01.016_bib0320","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.biopsych.2009.11.008","article-title":"Hippocampal synaptic plasticity, memory, and epilepsy: effects of long-term valproic acid treatment","volume":"67","author":"Sgobio","year":"2010","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2012.01.016_bib0325","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.pnpbp.2006.09.008","article-title":"Effects of sub-chronic lithium treatment on synaptic plasticity in the dentate gyrus of rat hippocampal slices","volume":"31","author":"Shim","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2012.01.016_bib0330","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/0006-8993(85)90537-2","article-title":"Surprisingly rich projection from locus coeruleus to the olfactory bulb in the rat","volume":"329","author":"Shipley","year":"1985","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2012.01.016_bib0335","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/j.neuroscience.2008.08.035","article-title":"Emotional, cognitive and neurochemical alterations in a premotor stage model of Parkinson's disease","volume":"156","author":"Tadaiesky","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2012.01.016_bib0340","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/archneur.1996.00550020087019","article-title":"The occurrence of depression in Parkinson's disease. A community-based study","volume":"53","author":"Tandberg","year":"1996","journal-title":"Arch Neurol"},{"key":"10.1016\/j.bbr.2012.01.016_bib0345","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1016\/S0169-409X(02)00153-9","article-title":"Mood stabilizers in Alzheimer's disease: symptomatic and neuroprotective rationales","volume":"54","author":"Tariot","year":"2002","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.bbr.2012.01.016_bib0350","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbr.2010.03.004","article-title":"Behavioral phenotyping of mouse models of Parkinson's disease","volume":"211","author":"Taylor","year":"2010","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2012.01.016_bib0355","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s00213-008-1311-8","article-title":"Lithium and cognitive enhancement: leave it or take it","volume":"202","author":"Tsaltas","year":"2009","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2012.01.016_bib0360","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.bbr.2007.03.017","article-title":"Enhancing effects of lithium on memory are not by-products of learning or attentional deficits","volume":"180","author":"Tsaltas","year":"2007","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2012.01.016_bib0365","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.neuroscience.2009.11.073","article-title":"Valproic acid reduces spatial working memory and cell proliferation in the hippocampus","volume":"166","author":"Umka","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2012.01.016_bib0370","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0166-4328(99)00077-7","article-title":"Dose-dependent impairment of inhibitory avoidance retention in rats by immediate post-training infusion of a mitogen-activated protein kinase kinase inhibitor into cortical structures","volume":"105","author":"Walz","year":"1999","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.bbr.2012.01.016_bib0375","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1037\/0735-7044.105.3.450","article-title":"Posttraining D1 receptor blockade impairs odor conditioning in neonatal rats","volume":"105","author":"Weldon","year":"1991","journal-title":"Behav Neurosci"},{"key":"10.1016\/j.bbr.2012.01.016_bib0380","doi-asserted-by":"crossref","first-page":"8145","DOI":"10.1523\/JNEUROSCI.18-20-08145.1998","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyride neurotoxicity is attenuated in mice overexpressing Bcl-2","volume":"18","author":"Yang","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2012.01.016_bib0385","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/j.neuropharm.2004.02.005","article-title":"Prevention of MPTP (N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) dopaminergic neurotoxicity in mice by chronic lithium: involvements of Bcl-2 and Bax","volume":"46","author":"Youdim","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.bbr.2012.01.016_bib0390","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00146965-200312000-00001","article-title":"A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry","volume":"16","author":"Zgaljardic","year":"2003","journal-title":"Cogn Behav Neurol"},{"key":"10.1016\/j.bbr.2012.01.016_bib0395","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3233\/JAD-2011-101875","article-title":"Long-term treatment with lithium alleviates memory deficits and reduces amyloid-beta production in an aged Alzheimer's disease transgenic mouse model","volume":"24","author":"Zhang","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.bbr.2012.01.016_bib0400","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.brainresbull.2010.07.008","article-title":"Neuroprotective effect and cognitive outcome of chronic lithium on traumatic brain injury in mice","volume":"83","author":"Zhu","year":"2010","journal-title":"Brain Res Bull"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432812000356?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432812000356?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T13:02:53Z","timestamp":1759064573000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432812000356"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S0166432812000356"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2012.01.016","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lithium and valproate prevent olfactory discrimination and short-term memory impairments in the intranasal 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) rat model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Behavioural Brain Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbr.2012.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}